Basics ADiTx Therapeutics, Inc. IPO Date: June 30, 2020 Sector: Healthcare Industry: Biotech Market Cap: $2.83M Activated in VL: True Average Daily Range Avg Daily Range: $0.22 | 5.94% Avg Daily Range (30 D): $0.04 | 3.20% Avg Daily Range (90 D): $0.19 | 6.01% Institutional Daily Volume Avg Daily Volume: 5.83M Avg Daily Volume (30 D): 1.16M Avg Daily Volume (90 D): 5.77M Trade Size Avg Trade Size (Sh.): 653 Avg Trade Size (Sh.) (30 D): 193 Avg Trade Size (Sh.) (90 D): 304 Institutional Trades Total Inst.Trades: 23 Avg Inst. Trade: $.7M Avg Inst. Trade (30 D): $.51M Avg Inst. Trade (90 D): $.6M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $.99M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: K     News Jul 15, 2025 @ 1:12 PM Phexxi -- A Non‑Hormonal Birth Control Bran... Source: Prnewswire Jun 25, 2025 @ 10:04 PM Appili Therapeutics Reports Fiscal Year 2025 Finan... Source: Don Cilla, President And Ceo Jun 11, 2025 @ 12:14 PM Notable Data on Evofem's SOLOSEC in Recurrent Bact... Source: Prnewswire Nov 6, 2024 @ 10:55 PM Appili Therapeutics Announces Results of Special M... Source: N/A Oct 10, 2024 @ 7:40 PM Appili Therapeutics – Press Release Correct... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $88368.8 $-8.12 Diluted EPS $88368.8 $-8.12 Revenue $ .06M $ M $ Gross Profit $ -.51M $ M $ Net Income / Loss $ -26.1M $ -5.95M $ Operating Income / Loss $ -21.94M $ -5.61M $ Cost of Revenue $ .56M $ M $ Net Cash Flow $ .74M $ M $ PE Ratio 0.00     Splits Mar 17, 2025:   1:250 Oct 02, 2024:   1:40 Aug 18, 2023:   1:40 Sep 14, 2022:   1:50